Asian Journal of Social Pharmacy

Editor-in-Chief: Huang Taikang

Asian Journal of Social Pharmacy (AJSP) is peer-reviewed quarterly journal jointly hosted by Shenyang Pharmaceutical University. AJSP is dedicated to providing researchers, pharmacists, administrators, and educators working within the field of pharmacy worldwide with a platform of communication in the advancement and development in social pharmacy. The journal.. More

ISSN: 1818-0884

Research on the Optimization of the Registration Classification of Biological Products in China

Li Zhiyi, Huang Zhe

2025, 20 (2): 99–105;

Abstract ( 13 ) PDF (842KB) ( 14 )

Exploring the Inheritance and Innovation of Traditional Chinese Medicine from the Perspective of Registration

Zhu Juncheng, Wang Shuling

2025, 20 (2): 106–115;

Abstract ( 8 ) PDF (2622KB) ( 10 )

Research on the Optimization of Pharmacovigilance Laws and Regulations in China

Zhang Zhi, Zhang Linlin, Feng Yuguo, Huang Jiaxin, Wang Huiyan, Sun Lihua

2025, 20 (2): 116–125;

Abstract ( 10 ) PDF (907KB) ( 9 )

Brief Discussion on the Enlightenment of FDA’s Comparability Protocol to the Post-Approval Change Management of New Drugs in China

Lu Xiaoling, Tian Lijuan

2025, 20 (2): 126–133;

Abstract ( 5 ) PDF (2300KB) ( 4 )

Visual Analysis of the Research Status of Active Surveillance of Drug Safety in China Based on CiteSpace

Xue Yisong, Chang Ping, Xing Hua

2025, 20 (2): 134–145;

Abstract ( 4 ) PDF (4978KB) ( 4 )

Quality Risk Management of the Changes of Sponsors and Production Sites of Drug Clinical Trial - Taking FDA’s Management as Reference

Yu Bing, Chen Zhen, Wu Zhiang, Yang Jianghong

2025, 20 (2): 146–157;

Abstract ( 5 ) PDF (2668KB) ( 9 )

Establishing New Mechanisms for Public-Private Partnerships to Address Common Challenges in Drug R&D

Dong Lijuan, Sun Lihua

2025, 20 (2): 158–164;

Abstract ( 7 ) PDF (946KB) ( 8 )

A Dual-Perspective Study on the Impact of Mergers and Acquisitions Companies on their Innovation Performance - Taking Company J as an Example

Dong Li, Li He

2025, 20 (2): 165–174;

Abstract ( 5 ) PDF (2714KB) ( 2 )

Relationship between R&D Investment and Enterprise Performance of Pharmaceutical Enterprises in China: Research on 45 Domestic Listed Pharmaceutical Companies Based on Panel Data

Fu Shuyong, Chen Shuyu, Zhang Qing

2025, 20 (2): 175–183;

Abstract ( 3 ) PDF (882KB) ( 3 )

A Cost-Effectiveness Analysis of Magnetic Resonance Imaging Contrast Agent for Early Diagnosis of Hepatocellular Carcinoma Based on Decision Tree + Partitioned Survival Model

Shang Yumeng, Zhang Fang, Dong Li

2025, 20 (2): 184–194;

Abstract ( 3 ) PDF (3113KB) ( 7 )

Asian Journal Of Social Pharmacy

Editor-in-Chief: Huang Taikang

Research on the Optimization of the Registration Classification of Biological Products in China

Exploring the Inheritance and Innovation of Traditional Chinese Medicine from the Perspective of Registration

Research on the Optimization of Pharmacovigilance Laws and Regulations in China

Brief Discussion on the Enlightenment of FDA’s Comparability Protocol to the Post-Approval Change Management of New Drugs in China

Visual Analysis of the Research Status of Active Surveillance of Drug Safety in China Based on CiteSpace

Quality Risk Management of the Changes of Sponsors and Production Sites of Drug Clinical Trial - Taking FDA’s Management as Reference

Establishing New Mechanisms for Public-Private Partnerships to Address Common Challenges in Drug R&D

A Dual-Perspective Study on the Impact of Mergers and Acquisitions Companies on their Innovation Performance - Taking Company J as an Example

Relationship between R&D Investment and Enterprise Performance of Pharmaceutical Enterprises in China: Research on 45 Domestic Listed Pharmaceutical Companies Based on Panel Data

A Cost-Effectiveness Analysis of Magnetic Resonance Imaging Contrast Agent for Early Diagnosis of Hepatocellular Carcinoma Based on Decision Tree + Partitioned Survival Model

Notice

Links

Asian Journal of Pharmaceutical Sciences

Asian Journal of Traditional Medicines

Journal of Polyphenols